As of 2024-09-10, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (5.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.36 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -169.5%.
The range of the Relative Valuation is (0.35) - (9.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.4x - 10.5x | 5.4x |
| Forward P/E multiples | 0.4x - 14.9x | 7.6x |
| Fair Price | (0.35) - (9.32) | (5.81) |
| Upside | -104.2% - -211.5% | -169.5% |
| Date | P/E |
| 2024-09-09 | -9.42 |
| 2024-09-06 | -9.45 |
| 2024-09-05 | -9.51 |
| 2024-09-04 | -9.50 |
| 2024-09-03 | -9.41 |
| 2024-08-30 | -9.94 |
| 2024-08-29 | -9.65 |
| 2024-08-28 | -10.13 |
| 2024-08-27 | -10.19 |
| 2024-08-26 | -10.15 |
| 2024-08-23 | -10.27 |
| 2024-08-22 | -10.07 |
| 2024-08-21 | -10.40 |
| 2024-08-20 | -9.96 |
| 2024-08-19 | -9.84 |
| 2024-08-16 | -9.14 |
| 2024-08-15 | -9.43 |
| 2024-08-14 | -9.00 |
| 2024-08-13 | -9.01 |
| 2024-08-12 | -9.00 |
| 2024-08-09 | -9.40 |
| 2024-08-08 | -9.05 |
| 2024-08-07 | -9.43 |
| 2024-08-06 | -8.89 |
| 2024-08-05 | -8.40 |
| 2024-08-02 | -8.77 |
| 2024-08-01 | -9.09 |
| 2024-07-31 | -9.53 |
| 2024-07-30 | -9.33 |
| 2024-07-29 | -9.21 |
| 2024-07-26 | -9.50 |
| 2024-07-25 | -9.33 |
| 2024-07-24 | -8.91 |
| 2024-07-23 | -9.07 |
| 2024-07-22 | -8.86 |
| 2024-07-19 | -8.85 |
| 2024-07-18 | -8.73 |
| 2024-07-17 | -9.01 |
| 2024-07-16 | -9.47 |
| 2024-07-15 | -9.50 |
| 2024-07-12 | -9.16 |
| 2024-07-11 | -8.56 |
| 2024-07-10 | -8.07 |
| 2024-07-09 | -7.27 |
| 2024-07-08 | -7.50 |
| 2024-07-05 | -7.52 |
| 2024-07-03 | -7.54 |
| 2024-07-02 | -7.53 |
| 2024-07-01 | -7.50 |
| 2024-06-28 | -7.71 |